Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552213 · ClinicalTrials.gov registry record · NA
Early Screening and Treatment of Women With Prediabetes in Pregnancy
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT01552213: Completed NA study, sponsored by Stanford University.
NCT01552213 is a NA study that has completed, run by Stanford University. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01552213, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The investigators hope to learn whether treatment with medical nutrition therapy (MNT) for pregnant women with prediabetes decreases the rate and severity of impaired glucose tolerance later in pregnancy and improves perinatal outcomes. Given the rising rates of obesity and diabetes in this country even among young women and the adverse affects of diabetes of pregnant women and their infants, the investigators feel that it is important to not only identify women at high risk for diabetes early in pregnancy but determine the appropriate management strategy
Interventions
- OTHER Minimum intervention control group
- OTHER Treatment for glucose intolerance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01552213
The ClinicalTrials.gov registry entry for NCT01552213 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Minimum intervention control group is the first listed.
NCT01552213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01552213 about?
NCT01552213 is a clinical study titled "Early Screening and Treatment of Women With Prediabetes in Pregnancy". The investigators hope to learn whether treatment with medical nutrition therapy (MNT) for pregnant women with prediabetes decreases the rate and severity of impaired glucose tolerance later in pregnancy and improves perinatal outcomes. Given the rising rates of obesity and diabetes in this country ...
What is the current status of trial NCT01552213?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2012-03. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01552213?
The interventions under investigation include: Minimum intervention control group (OTHER), Treatment for glucose intolerance (OTHER).
Who is sponsoring clinical trial NCT01552213?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.